Corteva (NYSE:CTVA) Insider Sells $636,207.05 in Stock

Corteva, Inc. (NYSE:CTVA) insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares in the company, valued at $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Corteva Stock Performance

CTVA stock opened at $78.79 on Friday. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $78.83. The business has a 50-day moving average price of $71.64 and a 200 day moving average price of $68.78. The company has a market capitalization of $52.99 billion, a P/E ratio of 49.87, a PEG ratio of 2.65 and a beta of 0.75. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter last year, the firm posted $0.32 EPS. The company’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is 45.57%.

Hedge Funds Weigh In On Corteva

Several hedge funds have recently modified their holdings of CTVA. Total Investment Management Inc. acquired a new stake in Corteva in the 2nd quarter worth approximately $27,000. Activest Wealth Management raised its holdings in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares during the last quarter. Curat Global LLC lifted its stake in shares of Corteva by 93.7% during the second quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after buying an additional 179 shares during the period. JPL Wealth Management LLC purchased a new stake in shares of Corteva during the third quarter valued at $25,000. Finally, True Wealth Design LLC increased its position in shares of Corteva by 209.5% in the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after acquiring an additional 264 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analysts Set New Price Targets

CTVA has been the topic of a number of analyst reports. CICC Research lifted their price target on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a report on Wednesday, February 11th. UBS Group lowered Corteva from a “buy” rating to a “hold” rating in a research note on Monday, February 9th. Mizuho boosted their target price on shares of Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a report on Tuesday, February 17th. Wolfe Research raised their price target on shares of Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Finally, Bank of America boosted their price objective on shares of Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $82.30.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.